Biogen Idec Inc. continues to defend itself in a lawsuit captioned United States of America ex rel. Paul P. McDermott v. Genentech Inc. and Biogen Idec Inc., filed on Jan. 6, 2006, in the U.S. District Court of the District…
The U.S. Department of Justice’s investigation of Genentech, Inc. relating to the promotion of RITUXAN, a cancer medication used in combination with other cancer medicines to treat non-Hodgkin’s lymphoma, is ongoing.
Biogen Idec Inc. markets RITUXAN in the U.S. in…
A hearing in the arbitration filed by Biogen Idec Inc. against Genentech, Inc. alleging breach of their Collaboration Agreement is scheduled to conclude in December 2008.
On June 17, 2006, the Company filed a Demand for Arbitration against Genentech with…